="研究事業"

  • このページを印刷する -

2024年8月 英文論文


NHO所属の著者を含む英文論文が177報出版されました。

内訳:北海道がんセンター(3)北海道医療センター(2)函館病院(1)旭川医療センター(3)岩手病院(1)仙台医療センター(4)水戸医療センター(4)栃木医療センター(2)高崎総合医療センター(3)渋川医療センター(2)埼玉病院(3)下志津病院(1)東京医療センター(5)災害医療センター(2)東京病院(6)横浜医療センター(3)久里浜医療センター(1)相模原病院(3)西新潟中央病院(1)新潟病院(1)甲府病院(1)信州上田医療センター(1)金沢医療センター(1)医王病院(1)静岡医療センター(1)名古屋医療センター(13)豊橋医療センター(1)三重病院(2)鈴鹿病院(1)あわら病院(1)京都医療センター(13)宇多野病院(2)舞鶴医療センター(1)大阪医療センター(14)近畿中央呼吸器センター(4)大阪刀根山医療センター(3)大阪南医療センター(1)姫路医療センター(4)兵庫中央病院(1)和歌山病院(1)米子医療センター(2)岡山医療センター(3)呉医療センター(5)福山医療センター(1)山口宇部医療センター(1)岩国医療センター(1)四国がんセンター(12)高知病院(2)九州がんセンター(9)九州医療センター(5)大牟田病院(2)肥前精神医療センター(1)嬉野医療センター(3)長崎医療センター(2)熊本医療センター(1)別府医療センター(1)都城医療センター(2)宮崎病院(3)鹿児島医療センター(3)


北海道がんセンター

#腫瘍学
Noguchi E, Yamanaka T, Mukai H, Yamamoto N, Chung CF, Lu YS, Chang DY, Sohn J, Kim GM, Lee KH, Lee SC, Iwasa T, Iwata H, Watanabe K, Jung KH, Tanabe Y, Kang SY, Yasojima H, Aogi K, Tokunaga E, Sim SH, Yap YS, Matsumoto K, Tseng LM, Umeyama Y, Sudo K, Kojima Y, Hata T, Kuchiba A, Shibata T, Nakamura K, Fujiwara Y, Tamura K, Yonemori K
A phase 3 study (PATHWAY) of palbociclib plus tamoxifen in patients with HR-positive/HER2-negative advanced breast cancer
npj Breast Cancer. 2024 AUG 22;10(1)
Journal Impact Factor 2021: 7.519

#腫瘍学
Nakatsumi H, Komatsu Y, Harada K, Kawamoto Y, Yuki S, Sawada K, Ishiguro A, Sogabe S, Ando T, Sasaki Y, Yoshikawa A, Nakamura M, Dazai M, Tateyama M, Muto O, Kotaka M, Sagawa T, Muranaka T, Hatanaka K, Takagi R, Sakata Y
A multicenter, prospective, phase II trial of second-line aflibercept plus FOLFIRI in patients with metastatic colorectal cancer refractory to an anti-EGFR antibody: HGCSG1801
Int J Cancer. 2024 DEC 15;155(12):2223-2231.
Journal Impact Factor 2021: 7.316

#腫瘍学
Nakayama T, Niikura N, Yamanaka T, Yamamoto M, Matsuura K, Inoue K, Takahara S, Nomura H, Kita S, Yamaguchi M, Aruga T, Shibata N, Shimomura A, Ozaki Y, Sakai S, Takiguchi D, Takata T, Bastanfard A, Shiosakai K, Tsurutani J
Trastuzumab deruxtecan for the treatment of patients with HER2-positive breast cancer with brain and/or leptomeningeal metastases: an updated overall survival analysis using data from a multicenter retrospective study (ROSET-BM)
Breast Cancer. 2024 NOV;31(6):1167-1175.
Journal Impact Factor 2021: 3.307


北海道医療センター

#臨床神経学 #レビュー論文
Niino M, Isobe N, Araki M, Ohashi T, Okamoto T, Ogino M, Okuno T, Ochi H, Kawachi I, Shimizu Y, Takahashi K, Takeuchi H, Tahara M, Chihara N, Nakashima I, Fukaura H, Misu T, Miyazaki Y, Miyamoto K, Mori M, Kinoshita M, Takai Y, Fujii C, Watanabe M, Fujihara K
Clinical practice guidelines for multiple sclerosis, neuromyelitis optica spectrum disorder, and myelin oligodendrocyte glycoprotein antibody-associated disease 2023 in Japan
Mult Scler Relat Disord. 2024 OCT;90
Journal Impact Factor 2021: 4.808

#腫瘍学
Nakatsumi H, Komatsu Y, Harada K, Kawamoto Y, Yuki S, Sawada K, Ishiguro A, Sogabe S, Ando T, Sasaki Y, Yoshikawa A, Nakamura M, Dazai M, Tateyama M, Muto O, Kotaka M, Sagawa T, Muranaka T, Hatanaka K, Takagi R, Sakata Y
A multicenter, prospective, phase II trial of second-line aflibercept plus FOLFIRI in patients with metastatic colorectal cancer refractory to an anti-EGFR antibody: HGCSG1801
Int J Cancer. 2024 DEC 15;155(12):2223-2231.
Journal Impact Factor 2021: 7.316


函館病院

#心臓 #循環器系 #多施設共同研究
Koya T, Nagai T, Tada A, Nakao M, Ishizaka S, Mizuguchi Y, Aoyagi H, George F, Imagawa S, Tokuda Y, Kato Y, Takahashi M, Sakai H, Machida M, Matsutani K, Saito T, Okamoto H, Anzai T, ELMSTAT-HF Investigators
Differential impacts of self-care behavior on clinical outcomes in patients with and without recent heart failure hospitalization
Int J Cardiol. 2024 NOV 15;415
Journal Impact Factor 2021: 4.039


旭川医療センター

#臨床神経学
Aizawa H, Nagumo S, Hideyama T, Kato H, Kwak S, Terashi H, Suzuki Y, Kimura T
Morphometric analysis of spinal motor neuron degeneration in sporadic amyotrophic lateral sclerosis
J Neurol Sci. 2024 SEP 15;464
Journal Impact Factor 2021: 4.553

#呼吸器系 #観察研究 #多施設共同研究
Taniguchi Y, Tamiya A, Osuga M, Harada D, Isa SI, Nakamura K, Mizumori Y, Shinohara T, Yanai H, Nakatomi K, Oki M, Mori M, Kuwako T, Yamazaki K, Tamura A, Ando M, Koh Y
Baseline genetic abnormalities and effectiveness of osimertinib treatment in patients with chemotherapy-naïve EGFR-mutated NSCLC based on performance status
BMC Pulm Med. 2024 AUG 24;24(1)
Journal Impact Factor 2021: 3.32

#腫瘍学 #多施設共同研究 #観察研究
Tamiya A, Osuga M, Harada D, Isa SI, Taniguchi Y, Nakamura K, Mizumori Y, Shinohara T, Yanai H, Nakatomi K, Oki M, Mori M, Kuwako T, Yamazaki K, Tamura A, Ando M, Koh Y
Mechanisms of resistance and correlation between pre-treatment co-alterations and p-prognosis to osimertinib in chemo-naïve advanced non-small cell lung cancer
Lung Cancer. 2024 SEP;195
Journal Impact Factor 2021: 6.081


岩手病院

#複合科学
Suzuki N, Kanzaki M, Koide M, Izumi R, Fujita R, Takahashi T, Ogawa K, Yabe Y, Tsuchiya M, Suzuki M, Harada R, Ohno A, Ono H, Nakamura N, Ikeda K, Warita H, Osana S, Oikawa Y, Toyohara T, Abe T, Rui ML, Ebihara S, Nagatomi R, Hagiwara Y, Aoki M
Sporadic inclusion body myositis-derived myotube culture revealed muscle cell-autonomous expression profiles
PLoS One. 2024 AUG 1;19(8)
Journal Impact Factor 2021: 3.752


仙台医療センター

#臨床神経学
Ohata K, Arai H, Ezura M, Iihara K, Kinouchi H, Kobayashi S, Tominaga T, Minematsu K, Murayama Y, Nakayama N, Sakai N, Yasaka M, Yoshimoto Y, Kobayashi S
Nationwide All-case Survey on the Efficacy and Safety of Flow Diverter: Multicenter Study Conducted by the Japan Neurosurgical Society
Neurol Med-Chir. 2024 AUG;64:1-106.
Journal Impact Factor 2021: 2.036

#複合科学
Fan YX, Nishimura H, Sakata S, Okada Y, Ebihara S, Tang JW, Kohzuki M
Minimal influenza virus transmission from touching contaminated face masks: a laboratory study
Sci Rep. 2024 AUG 30;14(1)
Journal Impact Factor 2021: 4.997

#放射線学 #核医学 #医用画像
Okuno T, Watanabe T, Yamaguchi T, Konno S, Takaki R, Watanabe R, Ban KAK, Hirokaga K, Tsuruoka M, Morita T
Usefulness of color Doppler and strain elastography adjunctive to B-mode ultrasonography in the diagnosis of non-mass abnormalities of the breast: results of the BC-07 multicenter study of 385 cases
J Med Ultrason. 2024 AUG 13;
Journal Impact Factor 2021: 1.878

#公衆衛生学 #環境衛生学 #労働衛生学
Koga M, Fukuda A, Nojima M, Ishizaka A, Itoh T, Eguchi S, Endo T, Kakinuma A, Kinai E, Goto T, Takahashi S, Takeda H, Tanaka T, Teruya K, Hanai J, Fujii T, Fujitani J, Hosaka T, Mita E, Minami R, Moro H, Yokomaku Y, Watanabe D, Watanabe T, Yotsuyanagi H
Non-acquired immunodeficiency syndrome defining malignancies in people living with haemophilia and human immunodeficiency virus after direct-acting antiviral era
Glob Health Medicine. 2024;6(5):316-323.


水戸医療センター

#免疫学 #観察研究 #多施設共同研究
Unagami K, Yoshikawa M, Egawa H, Ohfuji S, Natori Y, Oki R, Mori T, Hattori H, Ishiwatari A, Kanzawa T, Shimizu T, Omoto K, Inui M, Masano Y, Ito T, Nakajima D, Babazono T, Takagi T, Nunoda S, Tomimaru Y, Imamura R, Miyagawa S, Toda K, Hatano E, Date H, Kyakuno M, Takahara S, Yuzawa K, Tanimine N, Ohdan H, Ishida H, Hirota Y, Japan Solid Organ Transplantation COVID 19 Countermeasure Grp
Delayed peak antibody titers after the second dose of SARS-CoV-2 vaccine in solid organ transplant recipients: Prospective cohort study
Vaccine. 2024 OCT 3;42(23)
Journal Impact Factor 2021: 4.169

#神経科学
Aoki J, Suzuki K, Sakamoto Y, Matsumaru Y, Takeuchi M, Morimoto M, Kanazawa R, Takayama Y, Kamiya Y, Shigeta K, Okubo S, Hayakawa M, Ishii N, Koguchi Y, Takigawa T, Inoue M, Naito H, Ota T, Hirano T, Kato N, Ueda T, Iguchi Y, Akaji K, Tsuruta W, Miki K, Fujimoto S, Higashida T, Iwasaki M, Kanamaru T, Saito T, Katano T, Kutsuna A, Nishiyama Y, Otsuka T, Kimura K, SKIP study Investigators
High plasma BNP concentration associates with clinical outcome after mechanical thrombectomy: Post hoc analysis of SKIP
J Stroke Cerebrovasc Dis. 2024 NOV;33(11)
Journal Impact Factor 2021: 2.677

#呼吸器系 #観察研究 #多施設共同研究
Taniguchi Y, Tamiya A, Osuga M, Harada D, Isa SI, Nakamura K, Mizumori Y, Shinohara T, Yanai H, Nakatomi K, Oki M, Mori M, Kuwako T, Yamazaki K, Tamura A, Ando M, Koh Y
Baseline genetic abnormalities and effectiveness of osimertinib treatment in patients with chemotherapy-naïve EGFR-mutated NSCLC based on performance status
BMC Pulm Med. 2024 AUG 24;24(1)
Journal Impact Factor 2021: 3.32

#腫瘍学 #多施設共同研究 #観察研究
Tamiya A, Osuga M, Harada D, Isa SI, Taniguchi Y, Nakamura K, Mizumori Y, Shinohara T, Yanai H, Nakatomi K, Oki M, Mori M, Kuwako T, Yamazaki K, Tamura A, Ando M, Koh Y
Mechanisms of resistance and correlation between pre-treatment co-alterations and p-prognosis to osimertinib in chemo-naïve advanced non-small cell lung cancer
Lung Cancer. 2024 SEP;195
Journal Impact Factor 2021: 6.081


栃木医療センター

#免疫学
Shinjoh M, Yaginuma M, Yamaguchi Y, Tamura K, Furuichi M, Tsumura Y, Itaki R, Iqbal A, Maeda N, Narabayashi A, Kamei A, Shibata A, Yamada G, Nishida M, Kenichiro T, Chiga M, Shimoyamada M, Yoshida M, Fukushima N, Nakata Y, Fukushima H, Kawakami C, Narumi S, Sugaya N, Keio Pediatric Influenza Res Grp
Effectiveness of inactivated influenza vaccine in children during the 2023/ 24 season: The first season after relaxation of intensive COVID-19 measures
Vaccine. 2024 OCT 3;42(23)
Journal Impact Factor 2021: 4.169

#外科学 #症例報告
Yabusaki R, Arai A, Odagaki Y, Nakashima J, Nakamura K, Ishikawa H, Okonogi N, Aoki S, Tsuji H, Ozu C
Salvage robotic-assisted radical prostatectomy in a patient with recurrence after two sessions of heavy ion radiotherapy
J Surg Case Rep. 2024 AUG 19;2024(8)
Journal Impact Factor 2021: N/A


高崎総合医療センター

#心臓 #循環器系
Hatori K, Mohara J, Shibata S, Murata M, Fukuda N, Hiroi S, Koyano T
Cardiac calcified amorphous tumor in a patient with lung cancer
Gen Thorac Cardiovasc Surg Cases. 2024 AUG 13;3(1)

#腫瘍学
Hatanaka T, Saito N, Kakizaki S, Hiraoka A, Tada T, Kariyama K, Tani J, Takaguchi K, Itobayashi E, Ishikawa T, Toyoda H, Kawata K, Naganuma A, Yata Y, Ohama H, Matono T, Tada F, Nouso K, Morishita A, Tsutsui A, Nagano T, Nakamura S, Kumada T, Real Life Practice Experts HCC RELPEC Study Grp
Factors Affecting an Increase in Spleen Volume and Association of Spleen Volume Variation with the Clinical Outcomes of Atezolizumab and Bevacizumab Treatment for Hepatocellular Carcinoma: A Retrospective Analysis
Oncology. 2024 AUG 20;
Journal Impact Factor 2021: 3.734

#医学 #一般医療 #内科学 #症例報告
Tomaru N, Nakamura H, Makiguchi T, Yamada Y, Yokoo S
Necrotizing Fasciitis of the Lower Extremity Treated With Continuous Local Antibiotic Perfusion
Cureus J Med Sci. 2024 AUG 14;16(8)
Journal Impact Factor 2021: N/A


渋川医療センター

#呼吸器系 #観察研究 #多施設共同研究
Taniguchi Y, Tamiya A, Osuga M, Harada D, Isa SI, Nakamura K, Mizumori Y, Shinohara T, Yanai H, Nakatomi K, Oki M, Mori M, Kuwako T, Yamazaki K, Tamura A, Ando M, Koh Y
Baseline genetic abnormalities and effectiveness of osimertinib treatment in patients with chemotherapy-naïve EGFR-mutated NSCLC based on performance status
BMC Pulm Med. 2024 AUG 24;24(1)
Journal Impact Factor 2021: 3.32

#腫瘍学 #多施設共同研究 #観察研究
Tamiya A, Osuga M, Harada D, Isa SI, Taniguchi Y, Nakamura K, Mizumori Y, Shinohara T, Yanai H, Nakatomi K, Oki M, Mori M, Kuwako T, Yamazaki K, Tamura A, Ando M, Koh Y
Mechanisms of resistance and correlation between pre-treatment co-alterations and p-prognosis to osimertinib in chemo-naïve advanced non-small cell lung cancer
Lung Cancer. 2024 SEP;195
Journal Impact Factor 2021: 6.081


埼玉病院

#免疫学
Shinjoh M, Yaginuma M, Yamaguchi Y, Tamura K, Furuichi M, Tsumura Y, Itaki R, Iqbal A, Maeda N, Narabayashi A, Kamei A, Shibata A, Yamada G, Nishida M, Kenichiro T, Chiga M, Shimoyamada M, Yoshida M, Fukushima N, Nakata Y, Fukushima H, Kawakami C, Narumi S, Sugaya N, Keio Pediatric Influenza Res Grp
Effectiveness of inactivated influenza vaccine in children during the 2023/ 24 season: The first season after relaxation of intensive COVID-19 measures
Vaccine. 2024 OCT 3;42(23)
Journal Impact Factor 2021: 4.169

#薬理学 #薬学
Ishimura A, Ogawa C, Yatabe M, Tani K, Inoue M
Differences in fluidity and viscosity of brand-name and generic injectable ointment
Drug Discov Ther. 2024 AUG;18(4):265-268.
Journal Impact Factor 2021: N/A

#外科学
Ichikawa K, Tomita A, Suzuki Y, Hosoda S, Koto T, Inoue M
Isolated posterior capsule rupture secondary to blunt ocular trauma: Case presentation and literature review
Int J Surg Case Rep. 2024 SEP;122
Journal Impact Factor 2021: N/A


下志津病院

#整形外科学
Suzuki N, Eguchi Y, Hirai T, Takahashi T, Takahashi Y, Watanabe K, Banno T, Sakaki K, Maki S, Takano Y, Taniguchi Y, Aoki Y, Konishi T, Hiraizumi Y, Yamagata M, Hirakawa A, Ohtori S
Outcome of intradiscal condoliase injection therapy for patients with recurrent lumbar disc herniation
Asian Spine J. 2024 AUG;18(4):550-559.
Journal Impact Factor 2021: N/A


東京医療センター

#免疫学
Shinjoh M, Yaginuma M, Yamaguchi Y, Tamura K, Furuichi M, Tsumura Y, Itaki R, Iqbal A, Maeda N, Narabayashi A, Kamei A, Shibata A, Yamada G, Nishida M, Kenichiro T, Chiga M, Shimoyamada M, Yoshida M, Fukushima N, Nakata Y, Fukushima H, Kawakami C, Narumi S, Sugaya N, Keio Pediatric Influenza Res Grp
Effectiveness of inactivated influenza vaccine in children during the 2023/ 24 season: The first season after relaxation of intensive COVID-19 measures
Vaccine. 2024 OCT 3;42(23)
Journal Impact Factor 2021: 4.169

#薬理学 #薬学
Ishimura A, Ogawa C, Yatabe M, Tani K, Inoue M
Differences in fluidity and viscosity of brand-name and generic injectable ointment
Drug Discov Ther. 2024 AUG;18(4):265-268.
Journal Impact Factor 2021: N/A

#腫瘍学 #多施設共同研究
Shimizu H, Kodaira T, Kiyota N, Hayashi R, Nishino H, Asada Y, Mitani H, Hirayama Y, Onozawa Y, Nishio N, Hanai N, Ohkoshi A, Hara H, Monden N, Nagaoka M, Minami S, Fujii T, Tanaka K, Homma A, Yoshimoto S, Oridate N, Omori K, Ueda T, Okami K, Uemura H, Shiga K, Nakahira M, Asakage T, Saito Y, Sasaki K, Kitabayashi R, Ishikura S, Nishimura Y, Tahara M
Incidence and risk factors associated with the development of hypothyroidism after postoperative chemoradiotherapy for head and neck cancer patients with high-risk features: Supplementary analysis of JCOG1008
Oral Oncol. 2024 OCT;157
Journal Impact Factor 2021: 5.972

#医学 #研究 #実験
Wasano K, Nakagawa T, Kaga K, Ogawa K
The effect of aging and asymmetrical hearing on speech discrimination
Communications Med. 2024 AUG 21;4(1)

#外科学
Mizuno S, Shigeta K, Kato Y, Okui J, Morita S, Sonal S, Goldstone R, Berger D, Al-Masri R, Al-Masri M, Tajima Y, Kikuchi H, Hirata A, Nakadai J, Baba H, Sugiura K, Hoshino G, Seo Y, Makino A, Suzumura H, Suzuki Y, Adachi Y, Shimada T, Kondo T, Matsui S, Seishima R, Okabayashi K, Kitagawa Y, Kunitake H
Stratification of Stage II Colon Cancer Using Recurrence Prediction Value
Ann Surg. 2024 AUG;280(2):274-282.
Journal Impact Factor 2021: 13.787


災害医療センター

#神経科学
Aoki J, Suzuki K, Sakamoto Y, Matsumaru Y, Takeuchi M, Morimoto M, Kanazawa R, Takayama Y, Kamiya Y, Shigeta K, Okubo S, Hayakawa M, Ishii N, Koguchi Y, Takigawa T, Inoue M, Naito H, Ota T, Hirano T, Kato N, Ueda T, Iguchi Y, Akaji K, Tsuruta W, Miki K, Fujimoto S, Higashida T, Iwasaki M, Kanamaru T, Saito T, Katano T, Kutsuna A, Nishiyama Y, Otsuka T, Kimura K, SKIP study Investigators
High plasma BNP concentration associates with clinical outcome after mechanical thrombectomy: Post hoc analysis of SKIP
J Stroke Cerebrovasc Dis. 2024 NOV;33(11)
Journal Impact Factor 2021: 2.677

#神経科学
Ishikawa M, Takahashi S, Hirai S, Sato Y, Shigeta K, Yoshimura M, Yamamura T, Taira N, Ishiwada T, Karakama J, Sawada K, Obata Y, Yamada K, Yoshino Y, Ishii Y, Wakabayashi H, Fujita K, Fujii S, Sagawa H, Nemoto S, Maehara T, Sumita K
Efficacy of endovascular treatment for distal anterior cerebral artery aneurysms: A multicenter observational study
J Stroke Cerebrovasc Dis. 2024 NOV;33(11)
Journal Impact Factor 2021: 2.677


東京病院

#呼吸器系
Iida T, Sato M, Fukami T
Clinical analysis of progressive destroyed lung after lung cancer surgery
J Thorac Dis. 2024 AUG;16(8):5097-5109.
Journal Impact Factor 2021: 3.005

#呼吸器系 #レビュー論文
Kimura Y, Jo T, Matsui H, Yasunaga H
Clinical research using real-world data: A narrative review
Respir Investig. 2024 NOV;62(6):929-934.
Journal Impact Factor 2021: N/A

#神経科学
Aoki J, Suzuki K, Sakamoto Y, Matsumaru Y, Takeuchi M, Morimoto M, Kanazawa R, Takayama Y, Kamiya Y, Shigeta K, Okubo S, Hayakawa M, Ishii N, Koguchi Y, Takigawa T, Inoue M, Naito H, Ota T, Hirano T, Kato N, Ueda T, Iguchi Y, Akaji K, Tsuruta W, Miki K, Fujimoto S, Higashida T, Iwasaki M, Kanamaru T, Saito T, Katano T, Kutsuna A, Nishiyama Y, Otsuka T, Kimura K, SKIP study Investigators
High plasma BNP concentration associates with clinical outcome after mechanical thrombectomy: Post hoc analysis of SKIP
J Stroke Cerebrovasc Dis. 2024 NOV;33(11)
Journal Impact Factor 2021: 2.677

#呼吸器系 #観察研究 #多施設共同研究
Taniguchi Y, Tamiya A, Osuga M, Harada D, Isa SI, Nakamura K, Mizumori Y, Shinohara T, Yanai H, Nakatomi K, Oki M, Mori M, Kuwako T, Yamazaki K, Tamura A, Ando M, Koh Y
Baseline genetic abnormalities and effectiveness of osimertinib treatment in patients with chemotherapy-naïve EGFR-mutated NSCLC based on performance status
BMC Pulm Med. 2024 AUG 24;24(1)
Journal Impact Factor 2021: 3.32

#リウマチ学
Higuchi T, Oka S, Shimada K, Tsunoda S, Ito S, Okamoto A, Fujimori M, Nakamura T, Katayama M, Suzuki M, Saisho K, Shinohara S, Matsui T, Migita K, Nagaoka S, Tohma S, Furukawa H
Association of rare single-nucleotide variant MUC5B rs35705950 with interstitial lung disease in Japanese rheumatoid arthritis
RHEUMATOLOGY. 2024 AUG 19;
Journal Impact Factor 2021: 7.046

#腫瘍学 #多施設共同研究 #観察研究
Tamiya A, Osuga M, Harada D, Isa SI, Taniguchi Y, Nakamura K, Mizumori Y, Shinohara T, Yanai H, Nakatomi K, Oki M, Mori M, Kuwako T, Yamazaki K, Tamura A, Ando M, Koh Y
Mechanisms of resistance and correlation between pre-treatment co-alterations and p-prognosis to osimertinib in chemo-naïve advanced non-small cell lung cancer
Lung Cancer. 2024 SEP;195
Journal Impact Factor 2021: 6.081


横浜医療センター

#心臓 #循環器系
Matsui Y, Higuchi S, Mori F, Takehisa K, Kikuchi K, Kikuchi H, Hirobe K, Maeda R, Tsukamoto K, Saito T, Shoda M, Yamaguchi J
Microporous polysaccharide hemospheres for reducing pocket hematomas after cardiac device implantation in patients on antithrombotic therapy
J Arrythm. 2024 OCT;40(5):1150-1157.
Journal Impact Factor 2021: N/A

#泌尿器学 #腎臓学 #症例報告
Takanashi M, Asaoka M, Imano M, Fujioka A, Oishi Y, Matsuda G, Chiba S, Hirai K
Primary squamous cell carcinoma of the kidney with hepatic invasion
IJU Case Rep. 2024 SEP;7(5):408-413.

#臨床神経学
Kamogawa M, Tanino S, Miyahara K, Shuto T, Matsunaga S, Okada T, Noda N, Sekiguchi N, Suzuki K, Tanaka Y, Uriu Y
Surgical and radiosurgical outcomes for Koos grade 3 vestibular schwannomas
Neurosurg Rev. 2024 AUG 3;47(1)
Journal Impact Factor 2021: 2.8


久里浜医療センター

#心理学 #総合
Kawashima D, Kempe T, Koga Y, Kubota S, Tsujimoto T, Urata Y, Watanabe T, Kondo-Arita M
Development and Initial Validation of the Death Attitudes in Relationships Scale
Jpn Psychol Res. 2024 AUG 6;


相模原病院

#アレルギー #レビュー論文
Tanno LK, Perie A, Bernstein JA, Sublett JL, Davtyan K, Berard F, Pawankar R, Rostan MV, Chong HRR, Yanez A, Ansontegui IJ, Ebisawa M, Wong GWK, Morais-Almeida M, Martin B, Briand Y, Demoly P, Amer Acad Allergy Asthma & Immunology AAAAI, Amer Coll Allergy Asthma & Immunology ACAAI, Asia Pacific Association Allergy Asthma & Clinical Immunology APAAACI, French Allergy Soc, French WHO Collaborating Ctr, WHO Regional Off Europe, Latin Amer Soc Allergy & Immunology SLAAI, Montpellier WHO Collaborating Ctr World Allergy Org WAO
Allergic and hypersensitivity condition in the International Patients' Summary (IPS) standard: The need of updates through the International Classification of Diseases (ICD)-11
World Allergy Organ J. 2024 AUG;17(8)
Journal Impact Factor 2021: 5.516

#リウマチ学
Higuchi T, Oka S, Shimada K, Tsunoda S, Ito S, Okamoto A, Fujimori M, Nakamura T, Katayama M, Suzuki M, Saisho K, Shinohara S, Matsui T, Migita K, Nagaoka S, Tohma S, Furukawa H
Association of rare single-nucleotide variant MUC5B rs35705950 with interstitial lung disease in Japanese rheumatoid arthritis
RHEUMATOLOGY. 2024 AUG 19;
Journal Impact Factor 2021: 7.046

#アレルギー #レビュー論文
Leung ASY, Pacharn P, Tangvalelerd S, Sato S, Pitt E, Wong G, Koplin JJ
Food allergy in a changing dietary landscape: A focus on the Asia Pacific region
Pediatr Allergy Immunol. 2024 AUG;35(8)
Journal Impact Factor 2021: 5.464


西新潟中央病院

#遺伝学 #遺伝
Tamura T, Yamamoto KS, Tohyama J, Morioka I, Kanno H, Yamamoto T
Reciprocal chromosome translocation t(3;4)(q27;q31.2) with deletion of 3q27 and reduced FBXW7 expression in a patient with developmental delay, hypotonia, and seizures
J Hum Genet. 2024 DEC 1;69(12):639-644.
Journal Impact Factor 2021: 3.767


新潟病院

#臨床神経学
Hirayama T, Morioka H, Sugisawa T, Shibukawa M, Ebina J, Hanashiro S, Nagasawa J, Yanagihashi M, Okuni I, Nakajima T, Murakami Y, Yamanaka K, Ebihara S, Kano O
A preliminary study on the effects of long-term robot suit exercise training on gait function and quality of life in patients with spinal and bulbar muscular atrophy
J Clin Neurosci. 2024 OCT;128
Journal Impact Factor 2021: 2.116


甲府病院

#整形外科学 #症例報告 #レビュー論文
Kono H, Saito M, Sato N, Ochiai S, Ichikawa J, Wako M, Haro H, Hagino T
Chronic dislocations of the fourth and fifth carpometacarpal joints with successful treatment by ligament repair: A case report and literature review
Joint Dis Relat Surg. 2024;35(3):699-705.
Journal Impact Factor 2021: 1.549


信州上田医療センター

#腫瘍学 #多施設共同研究
Ozawa R, Sonehara K, Hachiya T, Nozawa S, Agatsuma T, Yamamoto H, Kato A, Matsuo A, Hirabayashi T, Araki T, Komatsu M, Tateishi K, Hanaoka M
Evaluation of the association between predictive factors and the development of immune-related adverse events and prognostic factors for chemoimmunotherapy in patients with non-small cell lung cancer: A multicenter retrospective study
Cancer Med. 2024 AUG;13(15)
Journal Impact Factor 2021: 4.711


金沢医療センター

#公衆衛生学 #環境衛生学 #労働衛生学
Sakai T, Ueda Y, Yanagisawa H, Arita K, Iwao H, Yamada K, Mizuta S, Kawabata H, Fukushima T, Tai KTNR, Kishi S, Morinaga K, Murakami J, Takamatsu H, Terasaki Y, Yoshio N, Kondo Y, Okumura H, Matano S, Yamaguchi M, Tsutani H, Masaki Y
Prospective therapeutic studies of disseminated extranodal large B-cell lymphoma including intravascular large B-cell lymphoma
Glob Health Medicine. 2024;6(4):277-281.


医王病院

#臨床神経学 #レビュー論文
Niino M, Isobe N, Araki M, Ohashi T, Okamoto T, Ogino M, Okuno T, Ochi H, Kawachi I, Shimizu Y, Takahashi K, Takeuchi H, Tahara M, Chihara N, Nakashima I, Fukaura H, Misu T, Miyazaki Y, Miyamoto K, Mori M, Kinoshita M, Takai Y, Fujii C, Watanabe M, Fujihara K
Clinical practice guidelines for multiple sclerosis, neuromyelitis optica spectrum disorder, and myelin oligodendrocyte glycoprotein antibody-associated disease 2023 in Japan
Mult Scler Relat Disord. 2024 OCT;90
Journal Impact Factor 2021: 4.808


静岡医療センター

#末梢血管疾患
Naito N, Takagi H
Systematic Review and Meta-Analysis With Reconstructed Time-To-Event Data of Frozen Elephant Trunk and Conventional Aortic Repair
Angiology. 2024 AUG 12;
Journal Impact Factor 2021: 3.299


名古屋医療センター

#血液学
Goto H, Kada A, Ogawa C, Nishiuchi R, Yamanaka J, Iguchi A, Nishi M, Sakaguchi K, Kumamoto T, Mochizuki S, Ueki H, Kosaka Y, Saito AM, Toyoda H
Treatment of relapsed acute lymphoblastic leukemia in children: an observational study of the Japan Children's Cancer Group
Int J Hematol. 2024 NOV;120(5):631-638.
Journal Impact Factor 2021: 2.324

#病理学
Toriyama K, Uehara T, Iwakoshi A, Kawashima H, Hosoda W
HNF6 and HNF4α expression in adenocarcinomas of the liver, pancreaticobiliary tract, and gastrointestinal tract: an immunohistochemical study of 480 adenocarcinomas of the digestive system
Pathology. 2024 OCT;56(6):804-813.
Journal Impact Factor 2021: 5.335

#腫瘍学
Yamamoto Y, Yukami H, Yamaguchi T, Ohori H, Nagasu S, Kagawa Y, Sugimoto N, Sonoda H, Yamazaki K, Takashima A, Okuyama H, Hasegawa H, Kondo C, Baba E, Matsumoto T, Kawamoto Y, Kataoka M, Shindo Y, Ishikawa T, Esaki T, Kito Y, Sato T, Funakoshi T, Yamaguchi T, Shimada Y, Moriwaki T
Real-world outcomes of FOLFOXIRI plus bevacizumab in patients with metastatic colorectal cancer: the JSCCR-TRIPON study
Int J Clin Oncol. 2024 AUG 28;
Journal Impact Factor 2021: 3.85

#腫瘍学
Akechi T, Furukawa TA, Hashimoto H, Harada Y, Ito Y, Furukawa Y, Kitano A, Maeda N, Kojima Y, Tada Y, Watanabe A, Kurata A, Matsubara T, Sakurai N, Uchitomi Y, Okamura M, Fujimori M
Smartphone-based distress screening, information provision, and psychotherapy for reducing psychological distress among AYA cancer survivors: protocol for a fully decentralized multicenter randomized controlled clinical trial
Jpn J Clin Oncol. 2024 AUG 28;54(12):1351-1357.
Journal Impact Factor 2021: 2.925

#血液学
Goto H, Kada A, Ogawa C, Nishiuchi R, Yamanaka J, Iguchi A, Nishi M, Sakaguchi K, Kumamoto T, Mochizuki S, Ueki H, Kosaka Y, Saito AM, Toyoda H
Treatment of relapsed acute lymphoblastic leukemia in children: an observational study of the Japan Children's Cancer Group
Int J Hematol. 2024 AUG 27;
Journal Impact Factor 2021: 2.324

#呼吸器系 #観察研究 #多施設共同研究
Taniguchi Y, Tamiya A, Osuga M, Harada D, Isa SI, Nakamura K, Mizumori Y, Shinohara T, Yanai H, Nakatomi K, Oki M, Mori M, Kuwako T, Yamazaki K, Tamura A, Ando M, Koh Y
Baseline genetic abnormalities and effectiveness of osimertinib treatment in patients with chemotherapy-naïve EGFR-mutated NSCLC based on performance status
BMC Pulm Med. 2024 AUG 24;24(1)
Journal Impact Factor 2021: 3.32

#腫瘍学
Hosoi H, Miyachi M, Teramukai S, Sakabayashi S, Tsuchiya K, Kuwahara Y, Onodera R, Matsuyama K, Yokota I, Hojo H, Okita H, Hata JI, Hamasaki M, Tsuneyoshi M, Oda Y, Nakazawa A, Kato M, Takimoto T, Horibe K, Hara JI, Suita S, Hanada R, Masaki H, Nozaki M, Ikeda H, Kishimoto S, Kaneko M, Kawai A, Morikawa Y
Results of the JRS-I LRA0401 and LRB0402 Japan Rhabdomyosarcoma Study Group trials for low-risk embryonal rhabdomyosarcoma
Int J Clin Oncol. 2024 NOV;29(11):1746-1755.
Journal Impact Factor 2021: 3.85

#血液学
Yokota H, Miyao K, Sawa M, Terakura S, Kurahashi S, Ikoma Y, Imahashi N, Morishita T, Okamoto A, Kajiguchi T, Ono T, Narita T, Kanemura N, Ozeki K, Kojima Y, Naito K, Uchino K, Tomita A, Iida H, Imoto N, Kasahara S, Inagaki Y, Nishida T, Murata M, Nagoya Blood & Marrow Transplantat Grp
Long-Term Outcome of Eltrombopag With First-Line Immunosuppressive Therapy for Newly Diagnosed Severe Aplastic Anemia
J Hematol. 2024 AUG;13(4):142-149.
Journal Impact Factor 2021: N/A

#リウマチ学
Higuchi T, Oka S, Shimada K, Tsunoda S, Ito S, Okamoto A, Fujimori M, Nakamura T, Katayama M, Suzuki M, Saisho K, Shinohara S, Matsui T, Migita K, Nagaoka S, Tohma S, Furukawa H
Association of rare single-nucleotide variant MUC5B rs35705950 with interstitial lung disease in Japanese rheumatoid arthritis
RHEUMATOLOGY. 2024 AUG 19;
Journal Impact Factor 2021: 7.046

#腫瘍学 #多施設共同研究 #観察研究
Tamiya A, Osuga M, Harada D, Isa SI, Taniguchi Y, Nakamura K, Mizumori Y, Shinohara T, Yanai H, Nakatomi K, Oki M, Mori M, Kuwako T, Yamazaki K, Tamura A, Ando M, Koh Y
Mechanisms of resistance and correlation between pre-treatment co-alterations and p-prognosis to osimertinib in chemo-naïve advanced non-small cell lung cancer
Lung Cancer. 2024 SEP;195
Journal Impact Factor 2021: 6.081

#放射線学 #核医学 #医用画像
Okuno T, Watanabe T, Yamaguchi T, Konno S, Takaki R, Watanabe R, Ban KAK, Hirokaga K, Tsuruoka M, Morita T
Usefulness of color Doppler and strain elastography adjunctive to B-mode ultrasonography in the diagnosis of non-mass abnormalities of the breast: results of the BC-07 multicenter study of 385 cases
J Med Ultrason. 2024 AUG 13;
Journal Impact Factor 2021: 1.878

#公衆衛生学 #環境衛生学 #労働衛生学
Koga M, Fukuda A, Nojima M, Ishizaka A, Itoh T, Eguchi S, Endo T, Kakinuma A, Kinai E, Goto T, Takahashi S, Takeda H, Tanaka T, Teruya K, Hanai J, Fujii T, Fujitani J, Hosaka T, Mita E, Minami R, Moro H, Yokomaku Y, Watanabe D, Watanabe T, Yotsuyanagi H
Non-acquired immunodeficiency syndrome defining malignancies in people living with haemophilia and human immunodeficiency virus after direct-acting antiviral era
Glob Health Medicine. 2024;6(5):316-323.

#放射線学 #核医学 #医用画像
Sunaguchi N, Yuasa T, Shimao D, Huang ZR, Ichihara S, Nishimura R, Iwakoshi A, Kim JK, Gupta R, Ando M
Phase-contrast visualization of human tissues using superimposed wavefront imaging of diffraction-enhanced x-rays
Med Phys. 2024 AUG 1;
Journal Impact Factor 2021: 4.506


豊橋医療センター

#物質乱用
Oya-Watanabe Y, Inagaki K, Nimi T, Yamamoto Y, Tanabe T, Okai M, Segawa N, Watanabe T, Uchibori N, Koide T, Inukai J, Yuasa H, Mitani A, Nagao T, Fukui M, Hinode D
Attitudes toward smoking cessation according to smoking status among dentists in the Aichi Dental Association in Japan
Tob Induc Dis. 2024 AUG;22
Journal Impact Factor 2021: 5.163


三重病院

#免疫学 #レビュー論文
Sunagawa T, Kobayashi Y, Takashima Y, Kamiya H, Shimada T, Nakashima K, Arai S, Taniguchi K, Tanaka-Taya K, Okabe N
Using Regular High-Quality Serosurveys to Identify and Close National Immunity Gaps-Measles and Rubella Elimination in Japan
Vaccines. 2024 AUG;12(8)
Journal Impact Factor 2021: 4.961

#小児科学 #多施設共同研究
Suzuki Y, Nagamitsu S, Eshima N, Inoue T, Otani R, Sakuta R, Iguchi T, Ishii R, Uchida S, Okada A, Kitayama S, Koyanagi K, Suzuki Y, Sumi Y, Takamiya S, Fujii C, Fukai Y
Body weight and eating attitudes influence improvement of depressive symptoms in children and pre-adolescents with eating disorders: a prospective multicenter cohort study
BMC Pediatr. 2024 AUG 27;24(1)
Journal Impact Factor 2021: 2.567


鈴鹿病院

#臨床神経学 #症例報告
Kuru S, Sakai M, Moriyoshi H, Miyahara H, Iwasaki Y
An autopsy case of progressive supranuclear palsy with severe corticospinal tract degeneration
Neuropathology. 2024 DEC;44(6):452-458.
Journal Impact Factor 2021: 2.076


あわら病院

#公衆衛生学 #環境衛生学 #労働衛生学
Sakai T, Ueda Y, Yanagisawa H, Arita K, Iwao H, Yamada K, Mizuta S, Kawabata H, Fukushima T, Tai KTNR, Kishi S, Morinaga K, Murakami J, Takamatsu H, Terasaki Y, Yoshio N, Kondo Y, Okumura H, Matano S, Yamaguchi M, Tsutani H, Masaki Y
Prospective therapeutic studies of disseminated extranodal large B-cell lymphoma including intravascular large B-cell lymphoma
Glob Health Medicine. 2024;6(4):277-281.


京都医療センター

#医学 #研究 #実験
Murata T, Sakane N, Hirota Y, Toyoda M, Matsuhisa M, Kuroda A, Itoh A, Meguro S, Miura J, Matoba Y, Kato K, Suzuki S, Shimada A
Difference in the accuracy of the third-generation algorithm and the first-generation algorithm of FreeStyle Libre continuous glucose monitoring device
J Med Investig. 2024 AUG;71(3-4):225-231.
Journal Impact Factor 2021: N/A

#泌尿器学 #腎臓学 #レビュー論文
Morizane S, Miki J, Shimbo M, Kanno T, Miura N, Yamada Y, Yamasaki T, Saika T, Takenaka A, A Working Grp Standardization
Japanese expert consensus on the standardization of robot-assisted pelvic lymph node dissection in urological surgery: Extent of pelvic lymph node and surgical technique
Int J Urol. 2024 DEC;31(12):1300-1310.
Journal Impact Factor 2021: 2.896

#消化器病学 #肝臓学 #レビュー論文
Sugimoto M, Murata M, Murakami K, Yamaoka Y, Kawai T
Characteristic endoscopic findings in Helicobacter pylori diagnosis in clinical practice
Expert Rev Gastroenterol Hepatol. 2024 AUG 2;18(8):457-472.
Journal Impact Factor 2021: 4.095

#生化学 #分子生物学
Yaku H, Takahashi K, Okada H, Kobiyama K, Shiokawa M, Uza N, Kodama Y, Ishii KJ, Seno H
Near-infrared photoimmunotherapy as a complementary modality to in situ vaccine in a preclinical pancreatic cancer model
Biochem Biophys Res Commun. 2024 DEC 10;737
Journal Impact Factor 2021: 3.322

#放射線学 #核医学 #医用画像
Nakamoto T, Nawa K, Nishiyama K, Yoshida K, Saito D, Horiguchi M, Shinya Y, Ohta T, Ozaki S, Nozawa Y, Minamitani M, Imae T, Abe O, Yamashita H, Nakagawa K
Neurological prognosis prediction for cardiac arrest patients using quantitative imaging biomarkers from brain computed tomography
Phys Medica. 2024 SEP;125
Journal Impact Factor 2021: 3.119

#内分泌学 #新陳代謝
Meguro S, Sakane N, Hosoda K, Hirota Y, Itoh A, Kato K, Kodani N, Kuroda A, Matsuhisa M, Miura J, Shimada A, Tone A, Toyoda M, Murata T, ISCHIA Study Grp
Diurnal variation in the association between the scan frequency of isCGM and CGM metrics: post hoc analysis of the ISCHIA study
Diabetol Int. 2024 OCT;15(4):828-836.
Journal Impact Factor 2021: N/A

#老年医学 #老年学 #多施設共同研究
Nishimura A, Masuda C, Murauchi C, Ishii M, Murata Y, Kawasaki T, Azuma M, Arai H, Harashima SI
Regional differences in frailty among older adults with type 2 diabetes: a multicenter cross-sectional study in Japan
BMC Geriatr. 2024 AUG 17;24(1)
Journal Impact Factor 2021: 4.07

#公衆衛生学 #環境衛生学 #労働衛生学
Onda M, Horiguchi M, Domichi M, Sakane N
Effect of a Smoking Cessation Education Program on the Knowledge, Attitude, and Self-Efficacy of Community Pharmacists in Japan: A Quasi-Experimental Study
Tob Use Insights. 2024 JUL;17
Journal Impact Factor 2021: N/A

#医学 #一般医療 #内科学
Adachi K, Murata M, Inada A, Morimoto T, Shimizu M, Beppu S, Yamazaki H
Interaction of a caffeine overdose with clinical doses of contraceptive ethinyl estradiol in a young woman
Acute Med Surg. 2024 JAN;11(1)
Journal Impact Factor 2021: N/A

#腫瘍学
Okamura R, Aoyama R, Tsunoda S, Yamashita Y, Hata H, Kinjo Y, Miki A, Kanaya S, Yamamoto M, Matsuo K, Manaka D, Tanaka E, Kawada H, Kondo M, Itami A, Kan T, Kadokawa Y, Ito T, Jikihara S, Kasahara K, Sakamoto T, Okumura S, Maekawa H, Nishigori T, Hisamori S, Obama K
Management challenges and the role of adjuvant chemotherapy in remnant gastric cancer: an analysis of 313 patients from the KEGG multicenter observational study
Gastric Cancer. 2024 NOV;27(6):1302-1310.
Journal Impact Factor 2021: 7.701

#病理学
Yamada Y, Küffer S, Sauer C, Hoki M, Shibuya S, Tsujii H, Ono K, Moriyoshi K, Date H, Yoshizawa A, Szolkowska M, Haga H, Ströbel P, Marx A
Immunohistochemistry for YAP1 N-terminus and C-terminus highlights metaplastic thymoma and high-grade thymic epithelial tumors by different staining patterns
Virchows Arch. 2024 SEP;485(3):461-469.
Journal Impact Factor 2021: 4.548

#公衆衛生学 #環境衛生学 #労働衛生学
Sakai T, Ueda Y, Yanagisawa H, Arita K, Iwao H, Yamada K, Mizuta S, Kawabata H, Fukushima T, Tai KTNR, Kishi S, Morinaga K, Murakami J, Takamatsu H, Terasaki Y, Yoshio N, Kondo Y, Okumura H, Matano S, Yamaguchi M, Tsutani H, Masaki Y
Prospective therapeutic studies of disseminated extranodal large B-cell lymphoma including intravascular large B-cell lymphoma
Glob Health Medicine. 2024;6(4):277-281.

#歯科学 #口腔外科 #口腔内科
Yoshida K
Peripherally induced movement disorders in the stomatognathic system after oral surgical or dental procedures
Oral Maxillofac Surg-Heidelb. 2024 DEC;28(4):1579-1586.
Journal Impact Factor 2021: N/A


宇多野病院

#臨床神経学 #レビュー論文
Niino M, Isobe N, Araki M, Ohashi T, Okamoto T, Ogino M, Okuno T, Ochi H, Kawachi I, Shimizu Y, Takahashi K, Takeuchi H, Tahara M, Chihara N, Nakashima I, Fukaura H, Misu T, Miyazaki Y, Miyamoto K, Mori M, Kinoshita M, Takai Y, Fujii C, Watanabe M, Fujihara K
Clinical practice guidelines for multiple sclerosis, neuromyelitis optica spectrum disorder, and myelin oligodendrocyte glycoprotein antibody-associated disease 2023 in Japan
Mult Scler Relat Disord. 2024 OCT;90
Journal Impact Factor 2021: 4.808

#臨床神経学 #症例報告
Ohara H, Kikutsuji N, Iguchi N, Kinoshita M
Efgartigimod combined with steroids as a fast-acting therapy for myasthenic crisis: a case report
BMC Neurol. 2024 AUG 22;24(1)
Journal Impact Factor 2021: 2.903


舞鶴医療センター

#ヘルスケア科学 #サービス #プロトコル論文 #ランダム化比較試験
Imai A, Matsuoka T, Nakayam C, Hashimo N, Sano M, Narumoto J
Effectiveness of a Virtual Reality Open-Air Bath Program inReducing Loneliness and Improving Brain Function for DementiaPrevention in Older Adults:Protocol for a Prospective RandomizedCrossover Study
JMIR RES Protoc. 2024;13
Journal Impact Factor 2021: N/A


大阪医療センター

#腫瘍学 #第II相試験 #多施設共同研究 #ランダム化比較試験
Raghav K, Siena S, Takashima A, Kato T, van den Eynde M, Pietrantonio F, Komatsu Y, Kawakami H, Peeters M, Andre T, Lonardi S, Yamaguchi K, Tie JN, Castro CG, Hsu HC, Strickler JH, Kim TY, Cha YJ, Barrios D, Yan Q, Kamio T, Kobayashi K, Boran A, Koga M, Allard J, Yoshino T
Trastuzumab deruxtecan in patients with HER2-positive advanced colorectal cancer (DESTINY-CRC02): primary results from a multicentre, randomised, phase 2 trial
Lancet Oncol. 2024 SEP;25(9)
Journal Impact Factor 2021: 54.433

#腫瘍学
Yamamoto Y, Yukami H, Yamaguchi T, Ohori H, Nagasu S, Kagawa Y, Sugimoto N, Sonoda H, Yamazaki K, Takashima A, Okuyama H, Hasegawa H, Kondo C, Baba E, Matsumoto T, Kawamoto Y, Kataoka M, Shindo Y, Ishikawa T, Esaki T, Kito Y, Sato T, Funakoshi T, Yamaguchi T, Shimada Y, Moriwaki T
Real-world outcomes of FOLFOXIRI plus bevacizumab in patients with metastatic colorectal cancer: the JSCCR-TRIPON study
Int J Clin Oncol. 2024 AUG 28;
Journal Impact Factor 2021: 3.85

#腫瘍学
Sudo K, Nakamura Y, Ueno M, Furukawa M, Mizuno N, Kawamoto Y, Okano N, Umemoto K, Asagi A, Ozaka M, Ohtsubo K, Shimizu S, Matsuhashi N, Itoh S, Matsumoto T, Satoh T, Okuyama H, Goto M, Hasegawa H, Yamamoto Y, Odegaard JI, Bando H, Yoshino T, Ikeda M, Morizane C
Clinical utility of BRCA and ATM mutation status in circulating tumour DNA for treatment selection in advanced pancreatic cancer
Br J Cancer. 2024 OCT 19;131(7):1158-1168.
Journal Impact Factor 2021: 9.082

#複合科学 #症例報告
Watanabe D, Okamoto N, Kobayashi Y, Suzuki H, Kato M, Saitoh S, Kanemura Y, Takenouchi T, Yamada M, Nakato D, Sato M, Tsunoda T, Kosaki K, Miya F
Biallelic structural variants in three patients with ERCC8-related Cockayne syndrome and a potential pitfall of copy number variation analysis
Sci Rep. 2024 AUG 26;14(1)
Journal Impact Factor 2021: 4.997

#皮膚病学 #症例報告
Hiraki T, Mori H, Misawa J, Yunoki M, Goto K
NRASQ61R-driven atypical melanocytic tumor with blue nevus-like morphology: A case report
J Cutan Pathol. 2024 DEC;51(12):948-953.
Journal Impact Factor 2021: 1.458

#消化器病学 #肝臓学 #多施設共同研究 #第II相試験 #ランダム化比較試験
Hori S, Yamasaki M, Yamamoto N, Harino T, Momose K, Yamashita K, Tanaka K, Sugimura K, Makino T, Takeno A, Shiraishi O, Motoori M, Miyata H, Kimura Y, Hirao M, Yasuda T, Yano M, Doki Y
The impact of time to postoperative recurrence on the prognosis of patients with esophageal cancer post recurrence: exploratory analysis of OGSG 1003
Esophagus. 2024 OCT;21(4):472-483.
Journal Impact Factor 2021: 3.671

#腫瘍学
Noguchi E, Yamanaka T, Mukai H, Yamamoto N, Chung CF, Lu YS, Chang DY, Sohn J, Kim GM, Lee KH, Lee SC, Iwasa T, Iwata H, Watanabe K, Jung KH, Tanabe Y, Kang SY, Yasojima H, Aogi K, Tokunaga E, Sim SH, Yap YS, Matsumoto K, Tseng LM, Umeyama Y, Sudo K, Kojima Y, Hata T, Kuchiba A, Shibata T, Nakamura K, Fujiwara Y, Tamura K, Yonemori K
A phase 3 study (PATHWAY) of palbociclib plus tamoxifen in patients with HR-positive/HER2-negative advanced breast cancer
npj Breast Cancer. 2024 AUG 22;10(1)
Journal Impact Factor 2021: 7.519

#血液学
Shimazu Y, Kanda J, Takakuwa T, Onda Y, Fukushima K, Hotta M, Fuchida SI, Uoshima N, Shimura Y, Tanaka H, Ohta K, Shibayama H, Kosugi S, Yagi H, Yoshihara S, Hosen N, Ito T, Shimazaki C, Matsumura I, Kuroda J, Takaori-Kondo A, Hino M
The impact of renal function on initial therapy in transplant-ineligible multiple myeloma patients
Ann Hematol. 2024 AUG 21;
Journal Impact Factor 2021: 4.03

#腫瘍学
Kusunoki C, Uemura M, Osaki M, Takiguchi N, Kitakaze M, Paku M, Sekido Y, Takeda M, Hata T, Hamabe A, Ogino T, Miyoshi N, Tei M, Kagawa Y, Kato T, Eguchi H, Doki Y
Postoperative venous thromboembolism after surgery for locally recurrent rectal cancer
BMC Cancer. 2024 AUG 20;24(1)
Journal Impact Factor 2021: 4.638

#内分泌学 #新陳代謝
Meguro S, Sakane N, Hosoda K, Hirota Y, Itoh A, Kato K, Kodani N, Kuroda A, Matsuhisa M, Miura J, Shimada A, Tone A, Toyoda M, Murata T, ISCHIA Study Grp
Diurnal variation in the association between the scan frequency of isCGM and CGM metrics: post hoc analysis of the ISCHIA study
Diabetol Int. 2024 OCT;15(4):828-836.
Journal Impact Factor 2021: N/A

#臨床神経学
Peacock M, Drumm B, Klein P, Raymond J, Huo XC, Chen YM, Abdalkader M, Schonewille WJ, Liu XF, Hu W, Li CH, Ji XM, Alemseged F, Liu LP, Siegler JE, Nagel S, Strbian D, Sacco S, Yaghi S, Qureshi MM, Fischer U, de Sousa DA, Yamagami H, Michel P, Puetz V, Mujanovic A, Marto JP, Kristoffersen ES, Sandset EC, Demeestere J, Hanning U, Novakovic R, Kenmuir C, Agid R, Romoli M, Diana F, Lobotesis K, Roi D, Masoud HE, Ma ALC, Zhu YY, Sang HF, Sun DP, Ton MD, Li FL, Nasreldein A, Jesser J, Kaesmacher J, Weyland CS, Meyer L, Yeo LLL, Yang QW, Thomalla G, Yang PF, Poli S, Campbell BCV, Qureshi AI, Chen HS, Zaidat OO, Qiu ZM, Nogueira RG, Jovin TG, Miao ZR, Nguyen TN, Banerjee S
Basilar artery occlusion management: An international survey of gender influence on management
Interv Neuroradiol. 2024 AUG 14;
Journal Impact Factor 2021: 1.764

#公衆衛生学 #環境衛生学 #労働衛生学
Koga M, Fukuda A, Nojima M, Ishizaka A, Itoh T, Eguchi S, Endo T, Kakinuma A, Kinai E, Goto T, Takahashi S, Takeda H, Tanaka T, Teruya K, Hanai J, Fujii T, Fujitani J, Hosaka T, Mita E, Minami R, Moro H, Yokomaku Y, Watanabe D, Watanabe T, Yotsuyanagi H
Non-acquired immunodeficiency syndrome defining malignancies in people living with haemophilia and human immunodeficiency virus after direct-acting antiviral era
Glob Health Medicine. 2024;6(5):316-323.

#腫瘍学
Ueda H, Takahashi H, Akita H, Tomimaru Y, Kobayashi S, Kubo M, Mukai Y, Toshiyama R, Sasaki K, Hasegawa S, Iwagami Y, Sakai K, Yamada D, Noda T, Asaoka T, Wada H, Gotoh K, Doki Y, Eguchi H
Prognostic impact of aberrant right hepatic artery involvement in patients with pancreatic cancer: A multicenter retrospective cohort study
J Surg Oncol. 2024 SEP;130(3):504-515.
Journal Impact Factor 2021: 2.885

#医学 #一般医療 #内科学 #症例報告
Nobe R, Ishida K, Togami Y, Ojima M, Sogabe T, Ohnishi M
Improving oxygenation in a patient with respiratory failure due to morbid obesity by applying airway pressure release ventilation: a case report
J Med Case Rep. 2024 AUG 5;18(1)


近畿中央呼吸器センター

#呼吸器系
Shimoda M, Tanaka Y, Ohe T, Ishiguro T, Suzuki A, Kurahara Y, Shimatani Y, Matsushima H, Kusano K, Ohta H, Yanagisawa S, Kozu Y, Yui T, Igarashi S, Kimizuka Y, Honda K, Otani S, Chiba S, Xu DJ, Mitsui M, Waseda Y, Ishii H
Validation of a diagnostic flowchart for tuberculous pleurisy in pleural fluid with high levels of adenosine deaminase
Respir Investig. 2024 NOV;62(6):963-969.
Journal Impact Factor 2021: N/A

#呼吸器系 #観察研究 #多施設共同研究
Taniguchi Y, Tamiya A, Osuga M, Harada D, Isa SI, Nakamura K, Mizumori Y, Shinohara T, Yanai H, Nakatomi K, Oki M, Mori M, Kuwako T, Yamazaki K, Tamura A, Ando M, Koh Y
Baseline genetic abnormalities and effectiveness of osimertinib treatment in patients with chemotherapy-naïve EGFR-mutated NSCLC based on performance status
BMC Pulm Med. 2024 AUG 24;24(1)
Journal Impact Factor 2021: 3.32

#複合科学
Yaga M, Hasegawa K, Ikeda S, Matsubara M, Hiroshima T, Kimura T, Shirai Y, Tansri W, Uehara H, Tachikawa M, Okairi Y, Sone M, Mori H, Kogue Y, Akamine H, Okuzaki D, Kawagishi K, Kawanaka S, Yamato H, Takeuchi Y, Okura E, Kanzaki R, Okami J, Nakamichi I, Nakane S, Kobayashi A, Iwazawa T, Tokunaga T, Yokouchi H, Yano Y, Uchida J, Mori M, Komuta K, Tachi T, Kuroda H, Kijima N, Kishima H, Ichii M, Futami S, Naito Y, Shiroyama T, Miyake K, Koyama S, Hirata H, Takeda Y, Funaki S, Shintani Y, Kumanogoh A, Hosen N
CD98 heavy chain protein is overexpressed in non-small cell lung cancer and is a potential target for CAR T-cell therapy
Sci Rep. 2024 AUG 2;14(1)
Journal Impact Factor 2021: 4.997

#腫瘍学
Morimoto K, Hamashima R, Yamada T, Yokoyama T, Kobayashi T, Tsuyuguchi K, Kanematsu T, Tamiya N, Tsuji T, Nakamura R, Katayama Y, Nishioka N, Iwasaku M, Tokuda S, Takayama K
Clinical significance of chronic pulmonary aspergillosis in lung cancer patients undergoing anticancer drug therapy
Thorac Cancer. 2024 SEP;15(26):1882-1888.
Journal Impact Factor 2021: 3.223


大阪刀根山医療センター

#呼吸器系 #観察研究 #多施設共同研究
Taniguchi Y, Tamiya A, Osuga M, Harada D, Isa SI, Nakamura K, Mizumori Y, Shinohara T, Yanai H, Nakatomi K, Oki M, Mori M, Kuwako T, Yamazaki K, Tamura A, Ando M, Koh Y
Baseline genetic abnormalities and effectiveness of osimertinib treatment in patients with chemotherapy-naïve EGFR-mutated NSCLC based on performance status
BMC Pulm Med. 2024 AUG 24;24(1)
Journal Impact Factor 2021: 3.32

#複合科学
Yaga M, Hasegawa K, Ikeda S, Matsubara M, Hiroshima T, Kimura T, Shirai Y, Tansri W, Uehara H, Tachikawa M, Okairi Y, Sone M, Mori H, Kogue Y, Akamine H, Okuzaki D, Kawagishi K, Kawanaka S, Yamato H, Takeuchi Y, Okura E, Kanzaki R, Okami J, Nakamichi I, Nakane S, Kobayashi A, Iwazawa T, Tokunaga T, Yokouchi H, Yano Y, Uchida J, Mori M, Komuta K, Tachi T, Kuroda H, Kijima N, Kishima H, Ichii M, Futami S, Naito Y, Shiroyama T, Miyake K, Koyama S, Hirata H, Takeda Y, Funaki S, Shintani Y, Kumanogoh A, Hosen N
CD98 heavy chain protein is overexpressed in non-small cell lung cancer and is a potential target for CAR T-cell therapy
Sci Rep. 2024 AUG 2;14(1)
Journal Impact Factor 2021: 4.997

#腫瘍学 #多施設共同研究 #観察研究
Tamiya A, Osuga M, Harada D, Isa SI, Taniguchi Y, Nakamura K, Mizumori Y, Shinohara T, Yanai H, Nakatomi K, Oki M, Mori M, Kuwako T, Yamazaki K, Tamura A, Ando M, Koh Y
Mechanisms of resistance and correlation between pre-treatment co-alterations and p-prognosis to osimertinib in chemo-naïve advanced non-small cell lung cancer
Lung Cancer. 2024 SEP;195
Journal Impact Factor 2021: 6.081


大阪南医療センター

#臨床神経学
Kamatani T, Kitaguchi K, Kashii M
Characteristics in patients with very early therapeutic response of condoliase chemonucleolysis for lumbar disc herniation
Neurosurg Rev. 2024 AUG 13;47(1)
Journal Impact Factor 2021: 2.8


姫路医療センター

#呼吸器系 #観察研究 #多施設共同研究
Taniguchi Y, Tamiya A, Osuga M, Harada D, Isa SI, Nakamura K, Mizumori Y, Shinohara T, Yanai H, Nakatomi K, Oki M, Mori M, Kuwako T, Yamazaki K, Tamura A, Ando M, Koh Y
Baseline genetic abnormalities and effectiveness of osimertinib treatment in patients with chemotherapy-naïve EGFR-mutated NSCLC based on performance status
BMC Pulm Med. 2024 AUG 24;24(1)
Journal Impact Factor 2021: 3.32

#リウマチ学
Higuchi T, Oka S, Shimada K, Tsunoda S, Ito S, Okamoto A, Fujimori M, Nakamura T, Katayama M, Suzuki M, Saisho K, Shinohara S, Matsui T, Migita K, Nagaoka S, Tohma S, Furukawa H
Association of rare single-nucleotide variant MUC5B rs35705950 with interstitial lung disease in Japanese rheumatoid arthritis
RHEUMATOLOGY. 2024 AUG 19;
Journal Impact Factor 2021: 7.046

#腫瘍学 #多施設共同研究 #観察研究
Tamiya A, Osuga M, Harada D, Isa SI, Taniguchi Y, Nakamura K, Mizumori Y, Shinohara T, Yanai H, Nakatomi K, Oki M, Mori M, Kuwako T, Yamazaki K, Tamura A, Ando M, Koh Y
Mechanisms of resistance and correlation between pre-treatment co-alterations and p-prognosis to osimertinib in chemo-naïve advanced non-small cell lung cancer
Lung Cancer. 2024 SEP;195
Journal Impact Factor 2021: 6.081

#腫瘍学
Okamura R, Aoyama R, Tsunoda S, Yamashita Y, Hata H, Kinjo Y, Miki A, Kanaya S, Yamamoto M, Matsuo K, Manaka D, Tanaka E, Kawada H, Kondo M, Itami A, Kan T, Kadokawa Y, Ito T, Jikihara S, Kasahara K, Sakamoto T, Okumura S, Maekawa H, Nishigori T, Hisamori S, Obama K
Management challenges and the role of adjuvant chemotherapy in remnant gastric cancer: an analysis of 313 patients from the KEGG multicenter observational study
Gastric Cancer. 2024 NOV;27(6):1302-1310.
Journal Impact Factor 2021: 7.701


兵庫中央病院

#神経科学
Noda Y, Sekiguchi K, Matoba S, Suehiro H, Nishida K, Matsumoto R
Real-time artificial intelligence-based texture analysis of muscle ultrasound data for neuromuscular disorder assessment
Clin Neurophys Pract. 2024;9:242-248.
Journal Impact Factor 2021: N/A


和歌山病院

#呼吸器系
Minakata Y, Sasaki S, Murakami Y, Kawabe K, Ono H
Processing of Sedentary Time and Its Reference Equation in Patients with COPD
Int J Chronic Obstr Pulm Dis. 2024;19:1931-1942.
Journal Impact Factor 2021: 2.893


米子医療センター

#医学 #研究 #実験 #症例報告
Oshima Y, Tanaka A, Fukuki M, Otsuki A, Hisatome I
A Case of High-Dose Intravenous MgSO4 and Hemoperfusion for Aconite Poisoning with Chronic Kidney Disease
Yonago Acta Med. 2024 AUG;67(3):270-279.
Journal Impact Factor 2021: 1.371

#泌尿器学 #腎臓学
Yamane H, Morizane S, Honda M, Muraoka K, Oono H, Isoyama T, Ono K, Sejima T, Kadowaki H, Takenaka A
Preoperative risk stratification models after radical cystectomy for bladder cancer: A multi-center study
Int J Urol. 2024 NOV;31(11):1278-1287.
Journal Impact Factor 2021: 2.896


岡山医療センター

#心臓 #循環器系 #症例報告
Monden Y, Une D, Furuta M, Yoshida K, Nakai M
Transatrial repair of a giant left ventricular pseudoaneurysm and ischaemic mitral regurgitation after myocardial infarction: case report
Eur Heart J-Case Rep. 2024 AUG 16;8(8)
Journal Impact Factor 2021: N/A

#小児科学 #症例報告
Fujiwara S, Higuchi Y, Furujo M, Goda M, Takigawa Y, Sato K, Hitomi K, Mukai W, Oiwa M
Seven-year-old boy with severe dyspnoea and influenza virus infection
J Paediatr Child Health. 2024 OCT;60(10):619-620.
Journal Impact Factor 2021: 1.929

#呼吸器系 #症例報告
Fujiwara M, Watanabe H, Takigawa Y, Goda M, Shiraha K, Inoue T, Matsuoka S, Kudo K, Sato A, Sato K, Fujiwara K, Shibayama T
Successful treatment of type B2 thymoma with steroid and radiotherapy
Respirol Case Rep. 2024 AUG;12(8)
Journal Impact Factor 2021: N/A


呉医療センター

#消化器病学 #肝臓学
Shibata Y, Sudo T, Tazuma S, Tanimine N, Onoe T, Shimizu Y, Yamaguchi A, Kuraoka K, Takahashi S, Tashiro H
Transmembrane serine protease 4 expression in the prognosis of radical resection for biliary tract cancer
World J Gastrointest Surg. 2024 AUG 27;16(8)
Journal Impact Factor 2021: 2.505

#外科学 #症例報告
Fujii T, Onoe T, Tanimine N, Shimizu Y, Tashiro H
Treatment of intractable isolated bile leakage occurring after right anterior sectionectomy for hepatocellular carcinoma: Right hepatico-jejunostomy
Int J Surg Case Rep. 2024 OCT;123
Journal Impact Factor 2021: N/A

#腫瘍学
Iwatani T, Sasaki K, Machida R, Shien T, Hara F, Fujisawa T, Takano Y, Kobayashi Y, Saimura M, Koizumi K, Terada M, Sasada S, Saito K, Sumiyoshi M, Iwata H
Status of incremental costs of first-line treatment recommended in Japanese clinical guidelines for metastatic breast cancer patients
Jpn J Clin Oncol. 2024 AUG 23;54(10):1093-1099.
Journal Impact Factor 2021: 2.925

#消化器病学 #肝臓学
Tanino F, Yamashita K, Nagata S, Kuwai T, Kamigaichi Y, Tanaka H, Tamaru Y, Takigawa H, Asayama N, Urabe Y, Shimamoto F, Oka S
Vertical margin distance in T1 colorectal carcinoma resected by endoscopic submucosal dissection affects prognosis after additional surgery
Int J Colorectal Dis. 2024 AUG 16;39(1)
Journal Impact Factor 2021: 2.796

#腫瘍学 #観察研究
Sunakawa Y, Sakamoto Y, Kawabata R, Ishiguro A, Akamaru Y, Kito Y, Takahashi M, Matsuyama J, Yabusaki H, Makiyama A, Suzuki T, Tsuda M, Yasui H, Hihara J, Takeno A, Inoue E, Ichikawa W, Fujii M
Tumor Response Predicts Survival Time of Nivolumab Monotherapy for Advanced Gastric Cancer: A Subgroup Analysis of the DELIVER Trial (JACCRO GC-08)
Oncologist. 2024 APR 6;29(8):e997-e1002.
Journal Impact Factor 2021: 5.837


福山医療センター

#医学 #一般医療 #内科学 #症例報告
Tsukada R, Iwasaki S, Ibuka S, Saka R
Littre's Hernia Incidentally Found During Laparoscopic Indirect Inguinal Hernia Repair in a Child
Cureus J Med Sci. 2024 AUG 9;16(8)
Journal Impact Factor 2021: N/A


山口宇部医療センター

#腫瘍学 #第II相試験 #多施設共同研究
Yoh K, Azuma K, Hayashi H, Nishio M, Chikamori K, Ichihara E, Watanabe Y, Asato T, Kitagawa T, Fram RJ, Ohe Y
A phase 2 study of mobocertinib as first-line treatment in Japanese patients with non-small cell lung cancer harboring EGFR exon 20 insertion mutations
Int J Clin Oncol. 2024 OCT;29(10):1461-1474.
Journal Impact Factor 2021: 3.85


岩国医療センター

#呼吸器系 #プロトコル論文
Nakamura N, Makimoto G, Tanaka T, Kato Y, Oze I, Kozuki T, Yokoyama T, Ichikawa H, Kuyama S, Hara N, Maeda Y, Hotta K
A randomized, open-label phase II study on the preventive effect of goshajinkigan against peripheral neuropathy induced by paclitaxel-containing chemotherapy: The OLCSG2101 study protocol
Respir Investig. 2024 SEP;62(5):897-900.
Journal Impact Factor 2021: N/A


四国がんセンター

#医学 #研究 #実験 #多施設共同研究
Sugihara N, Hashine K, Yamashita N, Sakamoto M, Terashita M, Funaki K, Saiki K, Sawada T, Kakuda T, Nishimura K, Fukumoto T, Miura N, Miyauchi Y, Kikugawa T, Saika T
Can Pelvic Lymph Node Dissection in Prostate Cancer Patients with a 5% Briganti Nomogram Cut-off Value Provide an Oncological Benefit? A Large Multi-Institutional Cohort Study in Japan
Acta Med Okayama. 2024 AUG;78(4):307-312.
Journal Impact Factor 2021: 0.744

#腫瘍学 #第III相試験 #ランダム化比較試験 #多施設共同研究
Colombo N, Biagioli E, Harano K, Galli F, Hudson E, Antill Y, Choi CH, Rabaglio M, Marmé F, Marth C, Parma G, Fariñas-Madrid L, Nishio S, Allan K, Lee YC, Piovano E, Pardo B, Nakagawa S, Mcqueen J, Zamagni C, Manso L, Takehara K, Tasca G, Ferrero A, Tognon G, Lissoni AA, Petrella M, Laudani ME, Rulli E, Uggeri S, Ginesta MPB, AtTEnd Study Grp
Atezolizumab and chemotherapy for advanced or recurrent endometrial cancer (AtTEnd): a randomised, double-blind, placebo-controlled, phase 3 trial
Lancet Oncol. 2024 SEP;25(9):1135-1146.
Journal Impact Factor 2021: 54.433

#腫瘍学 #第II相試験 #多施設共同研究
Honma Y, Monden N, Yamazaki K, Kano S, Satake H, Kadowaki S, Utsumi Y, Nakatogawa T, Takano R, Fujii K, Koroki Y, Aoyama J, Ouchi S, Ogawa T, Mccarthy S, Brookman-May SD, Mundle S, Li JH, Thaper D, Nagao T, Tada Y
Apalutamide and Goserelin for Androgen Receptor-Positive Salivary Gland Carcinoma: A Phase II Nonrandomized Clinical Trial, YATAGARASU
Clin Cancer Res. 2024 AUG 15;30(16):3416-3427.
Journal Impact Factor 2021: 13.801

#腫瘍学
Sudo K, Nakamura Y, Ueno M, Furukawa M, Mizuno N, Kawamoto Y, Okano N, Umemoto K, Asagi A, Ozaka M, Ohtsubo K, Shimizu S, Matsuhashi N, Itoh S, Matsumoto T, Satoh T, Okuyama H, Goto M, Hasegawa H, Yamamoto Y, Odegaard JI, Bando H, Yoshino T, Ikeda M, Morizane C
Clinical utility of BRCA and ATM mutation status in circulating tumour DNA for treatment selection in advanced pancreatic cancer
Br J Cancer. 2024 OCT 19;131(7):1158-1168.
Journal Impact Factor 2021: 9.082

#呼吸器系 #観察研究 #多施設共同研究
Taniguchi Y, Tamiya A, Osuga M, Harada D, Isa SI, Nakamura K, Mizumori Y, Shinohara T, Yanai H, Nakatomi K, Oki M, Mori M, Kuwako T, Yamazaki K, Tamura A, Ando M, Koh Y
Baseline genetic abnormalities and effectiveness of osimertinib treatment in patients with chemotherapy-naïve EGFR-mutated NSCLC based on performance status
BMC Pulm Med. 2024 AUG 24;24(1)
Journal Impact Factor 2021: 3.32

#腫瘍学
Nishina T, Boku N, Kurokawa Y, Sasaki K, Machida R, Yoshikawa T
A real-world survey on expensive drugs used as first-line chemotherapy in patients with HER2-negative unresectable advanced/recurrent gastric cancer in the stomach cancer study group of the Japan clinical oncology group
Jpn J Clin Oncol. 2024 AUG 24;54(10):1100-1106.
Journal Impact Factor 2021: 2.925

#呼吸器系 #プロトコル論文
Nakamura N, Makimoto G, Tanaka T, Kato Y, Oze I, Kozuki T, Yokoyama T, Ichikawa H, Kuyama S, Hara N, Maeda Y, Hotta K
A randomized, open-label phase II study on the preventive effect of goshajinkigan against peripheral neuropathy induced by paclitaxel-containing chemotherapy: The OLCSG2101 study protocol
Respir Investig. 2024 SEP;62(5):897-900.
Journal Impact Factor 2021: N/A

#腫瘍学 #多施設共同研究
Shimizu H, Kodaira T, Kiyota N, Hayashi R, Nishino H, Asada Y, Mitani H, Hirayama Y, Onozawa Y, Nishio N, Hanai N, Ohkoshi A, Hara H, Monden N, Nagaoka M, Minami S, Fujii T, Tanaka K, Homma A, Yoshimoto S, Oridate N, Omori K, Ueda T, Okami K, Uemura H, Shiga K, Nakahira M, Asakage T, Saito Y, Sasaki K, Kitabayashi R, Ishikura S, Nishimura Y, Tahara M
Incidence and risk factors associated with the development of hypothyroidism after postoperative chemoradiotherapy for head and neck cancer patients with high-risk features: Supplementary analysis of JCOG1008
Oral Oncol. 2024 OCT;157
Journal Impact Factor 2021: 5.972

#腫瘍学
Noguchi E, Yamanaka T, Mukai H, Yamamoto N, Chung CF, Lu YS, Chang DY, Sohn J, Kim GM, Lee KH, Lee SC, Iwasa T, Iwata H, Watanabe K, Jung KH, Tanabe Y, Kang SY, Yasojima H, Aogi K, Tokunaga E, Sim SH, Yap YS, Matsumoto K, Tseng LM, Umeyama Y, Sudo K, Kojima Y, Hata T, Kuchiba A, Shibata T, Nakamura K, Fujiwara Y, Tamura K, Yonemori K
A phase 3 study (PATHWAY) of palbociclib plus tamoxifen in patients with HR-positive/HER2-negative advanced breast cancer
npj Breast Cancer. 2024 AUG 22;10(1)
Journal Impact Factor 2021: 7.519

#腫瘍学 #多施設共同研究 #観察研究
Tamiya A, Osuga M, Harada D, Isa SI, Taniguchi Y, Nakamura K, Mizumori Y, Shinohara T, Yanai H, Nakatomi K, Oki M, Mori M, Kuwako T, Yamazaki K, Tamura A, Ando M, Koh Y
Mechanisms of resistance and correlation between pre-treatment co-alterations and p-prognosis to osimertinib in chemo-naïve advanced non-small cell lung cancer
Lung Cancer. 2024 SEP;195
Journal Impact Factor 2021: 6.081

#消化器病学 #肝臓学
Tsuji S, Doyama H, Kobayashi N, Ohata K, Takeuchi Y, Chino A, Takamaru H, Tsuji Y, Hotta K, Harada K, Ikematsu H, Uraoka T, Murakami T, Katagiri A, Hori S, Michida T, Suzuki T, Fukuzawa M, Kiriyama S, Fukase K, Murakami Y, Ishikawa H, Saito Y
Outcomes of noncurative endoscopic submucosal dissection for T1 colorectal cancer: Prospective, multicenter, cohort study in Japan
Dig Endosc. 2024 DEC;36(12):1369-1379.
Journal Impact Factor 2021: 6.337

#腫瘍学 #多施設共同研究 #観察研究
Kato T, Hirama H, Kamoto T, Goto T, Fujimoto H, Sakamoto S, Shinohara N, Egawa S, Kouguchi D, Nakayama M, Hashine K, Shimizu N, Inoue K, Habuchi T, Hioka T, Shiraishi T, Sugimoto M, Kakehi Y
Long-term outcomes of the first prospective study of active surveillance for prostate cancer in Japan
Int J Clin Oncol. 2024 OCT;29(10):1557-1563.
Journal Impact Factor 2021: 3.85


高知病院

#呼吸器系 #観察研究 #多施設共同研究
Taniguchi Y, Tamiya A, Osuga M, Harada D, Isa SI, Nakamura K, Mizumori Y, Shinohara T, Yanai H, Nakatomi K, Oki M, Mori M, Kuwako T, Yamazaki K, Tamura A, Ando M, Koh Y
Baseline genetic abnormalities and effectiveness of osimertinib treatment in patients with chemotherapy-naïve EGFR-mutated NSCLC based on performance status
BMC Pulm Med. 2024 AUG 24;24(1)
Journal Impact Factor 2021: 3.32

#腫瘍学 #多施設共同研究 #観察研究
Tamiya A, Osuga M, Harada D, Isa SI, Taniguchi Y, Nakamura K, Mizumori Y, Shinohara T, Yanai H, Nakatomi K, Oki M, Mori M, Kuwako T, Yamazaki K, Tamura A, Ando M, Koh Y
Mechanisms of resistance and correlation between pre-treatment co-alterations and p-prognosis to osimertinib in chemo-naïve advanced non-small cell lung cancer
Lung Cancer. 2024 SEP;195
Journal Impact Factor 2021: 6.081


九州がんセンター

#腫瘍学
Minato A, Furubayashi N, Tomoda T, Masaoka H, Song Y, Hori Y, Kiyoshima K, Negishi T, Kuroiwa K, Seki N, Tomisaki I, Nakamura M, Harada K, Fujimoto N
Clinical Outcomes of Enfortumab Vedotin in Advanced Urothelial Carcinoma With Prior Avelumab Versus Pembrolizumab Therapy
Anticancer Res. 2024 AUG;44(8):3419-3426.
Journal Impact Factor 2021: 2.435

#腫瘍学
Furubayashi N, Minato A, Tomoda T, Masaoka H, Hori Y, Kiyoshima K, Negishi T, Haraguchi Y, Koga T, Song YHY, Harada K, Kuroiwa K, Seki N, Fujimoto N, Nakamura M, Uro-Oncology Grp Kyushu UROKYU
Enfortumab Vedotin for Elderly Advanced Urothelial Carcinoma Patients or Those With a Poor Performance Status
Anticancer Res. 2024 AUG;44(8):3409-3417.
Journal Impact Factor 2021: 2.435

#腫瘍学
Yamamoto Y, Yukami H, Yamaguchi T, Ohori H, Nagasu S, Kagawa Y, Sugimoto N, Sonoda H, Yamazaki K, Takashima A, Okuyama H, Hasegawa H, Kondo C, Baba E, Matsumoto T, Kawamoto Y, Kataoka M, Shindo Y, Ishikawa T, Esaki T, Kito Y, Sato T, Funakoshi T, Yamaguchi T, Shimada Y, Moriwaki T
Real-world outcomes of FOLFOXIRI plus bevacizumab in patients with metastatic colorectal cancer: the JSCCR-TRIPON study
Int J Clin Oncol. 2024 AUG 28;
Journal Impact Factor 2021: 3.85

#腫瘍学
Sudo K, Nakamura Y, Ueno M, Furukawa M, Mizuno N, Kawamoto Y, Okano N, Umemoto K, Asagi A, Ozaka M, Ohtsubo K, Shimizu S, Matsuhashi N, Itoh S, Matsumoto T, Satoh T, Okuyama H, Goto M, Hasegawa H, Yamamoto Y, Odegaard JI, Bando H, Yoshino T, Ikeda M, Morizane C
Clinical utility of BRCA and ATM mutation status in circulating tumour DNA for treatment selection in advanced pancreatic cancer
Br J Cancer. 2024 OCT 19;131(7):1158-1168.
Journal Impact Factor 2021: 9.082

#外科学
Iseda N, Itoh S, Toshima T, Yoshiya S, Bekki Y, Tsutsui Y, Toshida K, Inokuchi S, Utsunomiya T, Tomino T, Sugimachi K, Morita K, Ninomiya M, Harada N, Minagawa R, Yoshizumi T
Outcome of hepatectomy after systemic therapy for hepatocellular carcinoma: a Japanese multicenter study
Surg Today. 2024 AUG 27;
Journal Impact Factor 2021: 2.54

#腫瘍学
Noguchi E, Yamanaka T, Mukai H, Yamamoto N, Chung CF, Lu YS, Chang DY, Sohn J, Kim GM, Lee KH, Lee SC, Iwasa T, Iwata H, Watanabe K, Jung KH, Tanabe Y, Kang SY, Yasojima H, Aogi K, Tokunaga E, Sim SH, Yap YS, Matsumoto K, Tseng LM, Umeyama Y, Sudo K, Kojima Y, Hata T, Kuchiba A, Shibata T, Nakamura K, Fujiwara Y, Tamura K, Yonemori K
A phase 3 study (PATHWAY) of palbociclib plus tamoxifen in patients with HR-positive/HER2-negative advanced breast cancer
npj Breast Cancer. 2024 AUG 22;10(1)
Journal Impact Factor 2021: 7.519

#消化器病学 #肝臓学 #多施設共同研究
Okamura A, Watanabe M, Okui J, Kuriyama K, Shiraishi O, Kurogochi T, Abe T, Sato H, Miyata H, Kawaguchi Y, Sato Y, Nagano H, Takeno S, Nakajima M, Matsuo K, Murakami K, Takebayashi K, Matsumoto S, Okumura T, Kakeji Y, Kono K, Oridate N, Toh Y, Takeuchi H, Katori Y, Joint Res Japan Bronchoesophagological Soc Japan Esophageal Soc
Esophagectomy for esophageal cancer in patients with a history of total pharyngolaryngectomy: a Japanese nationwide retrospective cohort study
Esophagus. 2024 OCT;21(4):438-446.
Journal Impact Factor 2021: 3.671

#腫瘍学
Muto Y, Kambayashi Y, Kato H, Mizuhashi S, Ito T, Maekawa T, Ishizuki S, Uchi H, Matsushita S, Yamamoto Y, Yoshino K, Fujisawa Y, Amagai R, Ohuchi K, Hashimoto A, Fukushima S, Asano Y, Fujimura T
Three-Year Analysis of Adjuvant Therapy in Postoperative Melanoma including Acral and Mucosal Subtypes
Cancers. 2024 AUG;16(15)
Journal Impact Factor 2021: 6.575

#免疫学
Nakashima K, Imai T, Shiraishi A, Unose R, Goto H, Nagatomo Y, Kojima-Ishii K, Mushimoto Y, Nishiyama K, Yamamura K, Nagata H, Ishimura M, Kusuhara K, Koga Y, Sakai Y, Ohga S
The immunoreactive signature of monocyte-derived dendritic cells from patients with Down syndrome
Clin Exp Immunol. 2024 JUN 28;217(3):291-299.
Journal Impact Factor 2021: 5.732


九州医療センター

#臨床神経学
Ohata K, Arai H, Ezura M, Iihara K, Kinouchi H, Kobayashi S, Tominaga T, Minematsu K, Murayama Y, Nakayama N, Sakai N, Yasaka M, Yoshimoto Y, Kobayashi S
Nationwide All-case Survey on the Efficacy and Safety of Flow Diverter: Multicenter Study Conducted by the Japan Neurosurgical Society
Neurol Med-Chir. 2024 AUG;64:1-106.
Journal Impact Factor 2021: 2.036

#呼吸器系 #観察研究 #多施設共同研究
Taniguchi Y, Tamiya A, Osuga M, Harada D, Isa SI, Nakamura K, Mizumori Y, Shinohara T, Yanai H, Nakatomi K, Oki M, Mori M, Kuwako T, Yamazaki K, Tamura A, Ando M, Koh Y
Baseline genetic abnormalities and effectiveness of osimertinib treatment in patients with chemotherapy-naïve EGFR-mutated NSCLC based on performance status
BMC Pulm Med. 2024 AUG 24;24(1)
Journal Impact Factor 2021: 3.32

#腫瘍学 #多施設共同研究 #観察研究
Tamiya A, Osuga M, Harada D, Isa SI, Taniguchi Y, Nakamura K, Mizumori Y, Shinohara T, Yanai H, Nakatomi K, Oki M, Mori M, Kuwako T, Yamazaki K, Tamura A, Ando M, Koh Y
Mechanisms of resistance and correlation between pre-treatment co-alterations and p-prognosis to osimertinib in chemo-naïve advanced non-small cell lung cancer
Lung Cancer. 2024 SEP;195
Journal Impact Factor 2021: 6.081

#公衆衛生学 #環境衛生学 #労働衛生学
Koga M, Fukuda A, Nojima M, Ishizaka A, Itoh T, Eguchi S, Endo T, Kakinuma A, Kinai E, Goto T, Takahashi S, Takeda H, Tanaka T, Teruya K, Hanai J, Fujii T, Fujitani J, Hosaka T, Mita E, Minami R, Moro H, Yokomaku Y, Watanabe D, Watanabe T, Yotsuyanagi H
Non-acquired immunodeficiency syndrome defining malignancies in people living with haemophilia and human immunodeficiency virus after direct-acting antiviral era
Glob Health Medicine. 2024;6(5):316-323.

#心臓 #循環器系
Yasaka M, Shimizu F, Niwa Y, Kiyonaga A, Terasaka N
Safety and Effectiveness of Four-Factor Prothrombin Complex Concentrate in Special Populations with INR Below 2: A Post-Marketing Surveillance Study
Cardiol Ther. 2024 SEP;13(3):603-614.
Journal Impact Factor 2021: N/A


大牟田病院

#呼吸器系
Wakamatsu K, Nagata N, Kumazoe H, Hara M, Asai S, Noda N, Kiyotani R, Fukui I, Tatsuta M, Katahira K, Akasaki T, Maki S, Miyamoto K, Otsuka J, Izumi M, Kawasaki M, Yamada H
Prognostic performance of Krebs von den Lungen-6, surfactant protein A, surfactant protein D levels in the serum and bronchoalveolar lavage fluid in chronic fibrosing interstitial pneumonia: a retrospective study
BMC Pulm Med. 2024 AUG 22;24(1)
Journal Impact Factor 2021: 3.32

#臨床神経学
Ono N, Suzuyama K, Minagawa H, Uwatoko K, Yoshikawa M, Ide T, Mitsuoka M, Honda K, Hirai T, Otsuka T, Kai KT, Honda H, Kitamoto T, Irie H, Yukitake M, Koike H
Involvement of the nigrostriatal system in Gerstman-Straussler-Scheinker disease with the PRNP-P102L mutation
J Neurol Sci. 2024 SEP 15;464
Journal Impact Factor 2021: 4.553


肥前精神医療センター

#臨床神経学 #レビュー論文
Kato T, Ogasawara K, Motomura K, Kato M, Tanaka T, Takaesu Y, Nio S, Kishi T, So MR, Nemoto K, Suzuki E, Watanabe K, Matsuo K, JSMD Bipolar Disorder Guidelines Revision Working Grp, JSMD Bipolar Disorder Comm, JSMD Gidelines Comm
Practice Guidelines for Bipolar Disorder by the JSMD (Japanese Society of Mood Disorders)
Psychiatry Clin Neurosci. 2024 NOV;78(11):633-645.
Journal Impact Factor 2021: 12.145


嬉野医療センター

#呼吸器系 #観察研究 #多施設共同研究
Taniguchi Y, Tamiya A, Osuga M, Harada D, Isa SI, Nakamura K, Mizumori Y, Shinohara T, Yanai H, Nakatomi K, Oki M, Mori M, Kuwako T, Yamazaki K, Tamura A, Ando M, Koh Y
Baseline genetic abnormalities and effectiveness of osimertinib treatment in patients with chemotherapy-naïve EGFR-mutated NSCLC based on performance status
BMC Pulm Med. 2024 AUG 24;24(1)
Journal Impact Factor 2021: 3.32

#外科学
Shiraishi T, Nonaka T, Tominaga T, Takamura Y, Oishi K, Hashimoto S, Noda K, Ono R, Hisanaga M, Takeshita H, Ishii M, Oyama S, Ishimaru K, Kunizaki M, Sawai T, Matsumoto K
The C-reactive protein-albumin-lymphocyte (CALLY) index is a useful predictor of postoperative complications in patients with a colonic stent for obstructive colorectal cancer: a Japanese multicenter study
Surg Today. 2024 AUG 23;
Journal Impact Factor 2021: 2.54

#腫瘍学 #多施設共同研究 #観察研究
Tamiya A, Osuga M, Harada D, Isa SI, Taniguchi Y, Nakamura K, Mizumori Y, Shinohara T, Yanai H, Nakatomi K, Oki M, Mori M, Kuwako T, Yamazaki K, Tamura A, Ando M, Koh Y
Mechanisms of resistance and correlation between pre-treatment co-alterations and p-prognosis to osimertinib in chemo-naïve advanced non-small cell lung cancer
Lung Cancer. 2024 SEP;195
Journal Impact Factor 2021: 6.081


長崎医療センター

#外科学
Shiraishi T, Nonaka T, Tominaga T, Takamura Y, Oishi K, Hashimoto S, Noda K, Ono R, Hisanaga M, Takeshita H, Ishii M, Oyama S, Ishimaru K, Kunizaki M, Sawai T, Matsumoto K
The C-reactive protein-albumin-lymphocyte (CALLY) index is a useful predictor of postoperative complications in patients with a colonic stent for obstructive colorectal cancer: a Japanese multicenter study
Surg Today. 2024 AUG 23;
Journal Impact Factor 2021: 2.54

#リウマチ学
Higuchi T, Oka S, Shimada K, Tsunoda S, Ito S, Okamoto A, Fujimori M, Nakamura T, Katayama M, Suzuki M, Saisho K, Shinohara S, Matsui T, Migita K, Nagaoka S, Tohma S, Furukawa H
Association of rare single-nucleotide variant MUC5B rs35705950 with interstitial lung disease in Japanese rheumatoid arthritis
RHEUMATOLOGY. 2024 AUG 19;
Journal Impact Factor 2021: 7.046


熊本医療センター

#血液学 #ランダム化比較試験 #第III相試験 #多施設共同研究
Shimoda K, Komatsu N, Matsumura I, Ikeda K, Hino M, Hidaka M, Maeda Y, Kondo T, Fujisaki T, Shoshi K, Azuma K, Fukushima R, Kawashima J, Kosugi H
Momelotinib versus ruxolitinib in JAK inhibitor-naïve patients with myelofibrosis: an efficacy/safety analysis in the Japanese subgroup of the phase 3 randomized SIMPLIFY-1 trial
Int J Hematol. 2024 SEP;120(3):314-324.
Journal Impact Factor 2021: 2.324


別府医療センター

#免疫学
Otsuki T, Akada S, Anami A, Kosaka K, Munjal I, Baber J, Shoji Y, Aizawa M, Swanson KA, Gurtman A
Efficacy and safety of bivalent RSVpreF maternal vaccination to prevent RSV illness in Japanese infants: Subset analysis from the pivotal randomized phase 3 MATISSE trial
Vaccine. 2024 SEP 17;42(22)
Journal Impact Factor 2021: 4.169


都城医療センター

#リウマチ学
Higuchi T, Oka S, Shimada K, Tsunoda S, Ito S, Okamoto A, Fujimori M, Nakamura T, Katayama M, Suzuki M, Saisho K, Shinohara S, Matsui T, Migita K, Nagaoka S, Tohma S, Furukawa H
Association of rare single-nucleotide variant MUC5B rs35705950 with interstitial lung disease in Japanese rheumatoid arthritis
RHEUMATOLOGY. 2024 AUG 19;
Journal Impact Factor 2021: 7.046

#外科学
Ogawa K, Komori H, Tajiri T, Horino T, Kato R, Ohuchi M, Miyamoto Y, Baba H
Association of Acute Care Surgeon Involvement With PostSurgery Complications
J Surg Res. 2024 SEP;301:640-646.
Journal Impact Factor 2021: 2.417


宮崎病院

#腫瘍学
Minato A, Furubayashi N, Tomoda T, Masaoka H, Song Y, Hori Y, Kiyoshima K, Negishi T, Kuroiwa K, Seki N, Tomisaki I, Nakamura M, Harada K, Fujimoto N
Clinical Outcomes of Enfortumab Vedotin in Advanced Urothelial Carcinoma With Prior Avelumab Versus Pembrolizumab Therapy
Anticancer Res. 2024 AUG;44(8):3419-3426.
Journal Impact Factor 2021: 2.435

#腫瘍学
Furubayashi N, Minato A, Tomoda T, Masaoka H, Hori Y, Kiyoshima K, Negishi T, Haraguchi Y, Koga T, Song YHY, Harada K, Kuroiwa K, Seki N, Fujimoto N, Nakamura M, Uro-Oncology Grp Kyushu UROKYU
Enfortumab Vedotin for Elderly Advanced Urothelial Carcinoma Patients or Those With a Poor Performance Status
Anticancer Res. 2024 AUG;44(8):3409-3417.
Journal Impact Factor 2021: 2.435

#老年医学 #老年学 #多施設共同研究
Nishimura A, Masuda C, Murauchi C, Ishii M, Murata Y, Kawasaki T, Azuma M, Arai H, Harashima SI
Regional differences in frailty among older adults with type 2 diabetes: a multicenter cross-sectional study in Japan
BMC Geriatr. 2024 AUG 17;24(1)
Journal Impact Factor 2021: 4.07


鹿児島医療センター

#臨床神経学
Hamada Y, Matsuoka H, Sato S, Kawabata Y, Iwamoto K, Ikeda M, Sato T, Takaguchi G, Takashima H
Combining the deployment of only the distal basket segment of the EMBOTRAP III and an aspiration catheter for M2 occlusions: the ONE-SEG technique
Front Neurol. 2024 AUG 27;15
Journal Impact Factor 2021: 4.086

#皮膚病学 #症例報告
Hiraki T, Mori H, Misawa J, Yunoki M, Goto K
NRASQ61R-driven atypical melanocytic tumor with blue nevus-like morphology: A case report
J Cutan Pathol. 2024 DEC;51(12):948-953.
Journal Impact Factor 2021: 1.458

#腫瘍学
Muto Y, Kambayashi Y, Kato H, Mizuhashi S, Ito T, Maekawa T, Ishizuki S, Uchi H, Matsushita S, Yamamoto Y, Yoshino K, Fujisawa Y, Amagai R, Ohuchi K, Hashimoto A, Fukushima S, Asano Y, Fujimura T
Three-Year Analysis of Adjuvant Therapy in Postoperative Melanoma including Acral and Mucosal Subtypes
Cancers. 2024 AUG;16(15)
Journal Impact Factor 2021: 6.575


登録日: 2025年1月15日

  • ページの先頭
  • 戻る
  • このページを印刷する -